Search Results for: us stem cell

Alliance for Regenerative Medicine (ARM) Opposes REGROW Act, Risks to Patients Cited

/ / 31 Comments
Alliance-for-Regenerative-Medicine

The biggest debate today in the stem cell world is over how much regulation is needed for new, investigational stem cell therapies that are not as yet approved. Sometimes it feels very lonely being out there publicly advocating for appropriately thorough regulation of stem cell therapies and at times I get a lot of heat for […]

Alliance for Regenerative Medicine (ARM) Opposes REGROW Act, Risks to Patients Cited Read More »

Interview with Bioheart CSO, Kristin Comella including on FDA

/ / 13 Comments
Kristin-Comella1

I invited the Chief Scientific Officer (CSO) of Bioheart, Kristin Comella, to do an interview after hearing some buzz that this could be a critical time for the company and that it might have been recently visited by the FDA. Note that Comella not just Bioheart CSO, but also the primary instructor for physician training in stem

Interview with Bioheart CSO, Kristin Comella including on FDA Read More »

Clinicaltrials.gov Mission At Risk From Proliferating For-Profit Trials

/ / 3 Comments
slickstem

It’s hard to even imagine the world of investigative medicine without the wonderful resource of Clinicaltrials.gov, the global hub for clinical trial listings. I recently interviewed the Director of Clinicaltrials.gov, Dr. Deborah Zarin here, which is a fascinating read. As great as Clinicaltrials.gov is as a resource, unfortunately it faces a new, rapidly growing problem that is a serious

Clinicaltrials.gov Mission At Risk From Proliferating For-Profit Trials Read More »

Blog readers investigate BioGatekeeper, the Yamanaka patent challenger

/ / 26 Comments
Nobel-Lawsuit

Who is trying, via the name BioGatekeeper, Inc., to nullify Yamanaka’s patent on cellular reprogramming to produce induced pluripotent stem (iPS) cells? The readers of this blog never cease to amaze me. What an informed, energetic, bright group. Within just days they may have collectively shed some light on an intriguing mystery in the stem cell field surrounding the

Blog readers investigate BioGatekeeper, the Yamanaka patent challenger Read More »

Pages: 1 2

23andMe and the FDA: Perspectives on Warning Letter

/ / 5 Comments
23andMe

What’s the deal with this week’s FDA Warning Letter to 23andMe? First some background. I’m a researcher who studies stem and cancer cell genomics and epigenomics. I’m also a human being who has battled prostate cancer and is curious about my genome. With this background, I decided some time ago to take the plunge and experience what

23andMe and the FDA: Perspectives on Warning Letter Read More »

Interview with Regenerative Surgeon, Dr. Allan Wu

/

Over the last few weeks, I have enjoyed talking with and interviewing Dr. Allan Wu, of The Morrow Institute on stem cell cosmetic procedures. I was impressed greatly by his talk at the World Stem Cell Summit last year. Dr. Wu is a fellowship trained Surgical Molecular Biologist with a background in Molecular Embryology and a board

Interview with Regenerative Surgeon, Dr. Allan Wu Read More »

The Moriguchi iPS transplant fable: key lessons & where do we go from here

/ / 1 Comment

More and more evidence is accumulating that the alleged iPS cell transplantation in human patients by Dr. Hisashi Moriguchi was bunk. Nature today has a piece out today on the story providing more quotes about the case that suggest the whole thing was made up. Rather than re-hash all the details, in this post I’m going

The Moriguchi iPS transplant fable: key lessons & where do we go from here Read More »

NASA’s wickedly up & down week: broader lessons about science & medicine

/

All science, whether biology or physics, whether microscopic or at the solar system level, is about experiments. Sometimes we as a society forget that. In fact, experiments are at the heart of investigations as diverse as studying cells to exploring space to medical treatments. For NASA, the last week has been a tale of two

NASA’s wickedly up & down week: broader lessons about science & medicine Read More »